With the rising popularity of semaglutide for weight management, its essential for patients to understand how to store it properly, how long it lasts, and what factors can influence its shelf life
Within the GLP-1RA user group undergoing same-day procedures, 2/43 (4.7%) also had retained gastric contents on EGD, vs
GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
The FDA has not approved retatrutide and the compound cannot lawfully be used in compounding under U.S